Farida Latif

23.9k citations

190 papers · 14.2k indexed · 3 hit papers · h-index 69

Impact in

Cancer Research top 0.1%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Molecular Biology top 0.2%
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- RNA modifications and cancer
- Renal and related cancers

Papers in

Cancer Research 49
- Cancer, Hypoxia, and Metabolism 26
- Cancer Genomics and Diagnostics 18
Molecular Biology 148
- Epigenetics and DNA Methylation 73
- Cancer-related gene regulation 40
- RNA modifications and cancer 25
- Renal and related cancers 18

Co-authors: Eamonn R. Maher Michael I. Lerman Ashraf Dallol Luke B. Hesson Berton Zbar Wendy N. Cooper Angelo Agathanggelou Mark R. Morris
Journals: Nucleic Acids Research (25 papers)Oncogene (24 papers)Cancer Research (12 papers)Epigenetics (12 papers)Human Genetics (9 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

Farida Latif

189 papers receiving 14.0k citations

Hit Papers

align trajectories log scale

Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma 2001 · 840 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2001 The American Journal of Human Genetics
2001 JNCI Journal of the National Cancer Institute
1994 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Farida Latif

Since Specialization

Citations

This map shows the geographic impact of Farida Latif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farida Latif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farida Latif more than expected).

Fields of papers citing papers by Farida Latif

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farida Latif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farida Latif. The network helps show where Farida Latif may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Farida Latif, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Farida Latif Line = papers co-authored together Farida Latif links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma Clinical Epigenetics ·Christopher J. Ricketts, Mark R. Morris, Dean Gentle, Salwati Shuib, Michael D. Brown, Noel W. Clarke, Wenbin Wei, Paul Nathan, Farida Latif, Eamonn R. Maher	2013	35
2	RASSF2methylation is a strong prognostic marker in younger age patients with Ewing sarcoma Epigenetics ·Seley Gharanei, A.T. Brini, Sumathi Vaiyapuri, 陈大林, Ashraf Dallol, E. Arrigoni, Takeshi Kishida, Toru Hiruma, Smadar Avigad, R. J. Grimer, Eamonn R. Maher, Farida Latif	2013	24
3	Genome-Wide DNA Methylation Profiling of CpG Islands in Breast Cancer Identifies Novel Genes Associated with Tumorigenicity Cancer Research ·Victoria Hill, Christopher J. Ricketts, Ivan Bièche, Sophie Vacher, Dean Gentle, Cheryl Lewis, Eamonn R. Maher, Farida Latif	2011	126
4	Therapeutic Targeting the Loss of the Birt-Hogg-Dubé Suppressor Gene Molecular Cancer Therapeutics ·Xiaohong Lü, Wenbin Wei, Janine Fenton, Michael S. Nahorski, Anny Vitória Ribeiro Silva, Anne Reiman, Bruce Cords, Zsuzsanna Nagy, Farida Latif, Eamonn R. Maher	2011	15
5	CpG Island Hypermethylation in Human Astrocytomas Cancer Research ·Xiwei Wu, Tibor A. Rauch, Xueyan Zhong, William P. Bennett, Farida Latif, Dietmar Krex, Gerd P. Pfeifer	2010	105
6	Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility Endocrine Related Cancer ·Dewi Astuti, Christopher J. Ricketts, Rasheduzzaman Chowdhury, M.A. McDonough, Dean Gentle, Gail Kirby, Susanne Schlisio, Rajappa S. Kenchappa, Tia Lombardi, William G. Kaelin, Peter J. Ratcliffe, Christopher J. Schofield, Farida Latif, Eamonn R. Maher	2010	48
7	Depletion of the Ras Association Domain Family 1, Isoform A–Associated Novel Microtubule-Associated Protein, C19ORF5/MAP1S, Causes Mitotic Abnormalities Cancer Research ·Ashraf Dallol, Wendy N. Cooper, Fahd Al‐Mulla, Angelo Agathanggelou, Eamonn R. Maher, Farida Latif	2007	42
8	Identification of novel VHL targets that are associated with the development of renal cell carcinoma Oncogene ·Mahera Abdulrahman, Esther N. Maina, Mark R. Morris, Malgorzata Zatyka, Raju R. Raval, Rosamonde E. Banks, Michael S. Wiesener, Frances M. Richards, Claire M. Johnson, Farida Latif, Eamonn R. Maher	2006	17
9	Involvement of the RASSF1A Tumor Suppressor Gene in Controlling Cell Migration Cancer Research ·Ashraf Dallol, Angelo Agathanggelou, Stella Tommasi, Gerd P. Pfeifer, Eamonn R. Maher, Farida Latif	2005	76
10	Tumor Suppressor Activity and Epigenetic Inactivation of Hepatocyte Growth Factor Activator Inhibitor Type 2/SPINT2 in Papillary and Clear Cell Renal Cell Carcinoma Cancer Research ·Mark R. Morris, Dean Gentle, Mahera Abdulrahman, Esther N. Maina, Kunal Gupta, Rosamonde E. Banks, Michael S. Wiesener, Takeshi Kishida, Masahiro Yao, Bin Tean Teh, Farida Latif, Eamonn R. Maher	2005	95
11	Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas Endocrine Related Cancer ·S. Sumanth Kori, Dewi Astuti, Dean Gentle, Wendy N. Cooper, Alberto Cascón, Daniel Catchpoole, Mercedes Robledo, Hartmut P.H. Neumann, Farida Latif, Eamonn R. Maher	2005	55
12	A Role for the RASSF1A Tumor Suppressor in the Regulation of Tubulin Polymerization and Genomic Stability Cancer Research ·Michele D. Vos, Alfredo Martı́nez, امیر اشرف آریان پور, Ashraf Dallol, Barbara J. Taylor, Farida Latif, Geoffrey Clark	2004	132
13	Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma Journal of Clinical Pathology ·Mark R. Morris, Esther N. Maina, Neil V. Morgan, Dean Gentle, Dewi Astuti, Holger Moch, Takeshi Kishida, Masahiro Yao, Peter Schraml, Frances M. Richards, Farida Latif, Eamonn R. Maher	2004	56
14	Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development. PubMed ·Meryl E. Lusher, Janet C. Lindsey, Farida Latif, Andrew D.J. Pearson, David W. Ellison, Steven C. Clifford	2002	63
15	Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers Oncogene ·Ashraf Dallol, Éva Forgács, Alonso Martínez, Yoshitaka Sekido, Rosemary A. Walker, Takeshi Kishida, Pamela Rabbitts, Eamonn R. Maher, John D. Minna, Farida Latif	2002	94
16	Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. PubMed ·SajanZ Ahmad, Sergio Marchini, Janet S. Rader, Alonso Martínez, Donia Macartney‐Coxson, Massimo Broggini, Maria Cristina Morelli, Giuseppe Barbanti‐Brodano, Eamonn R. Maher, Farida Latif	1999	48
17	Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect Human Genetics ·Hiltrud Brauch, Takeshi Kishida, Damjan Glavač, Fan Chen, Friederike Pausch, Heinz Höfler, Farida Latif, Michael I. Lerman, Berton Zbar, Hartmut P.H. Neumann	1995	140
18	Clinical and molecular analyses of deletion 3p25‐pter syndrome American Journal of Medical Genetics ·Philip N. Mowrey, Michael J. Chorney, Charles P. Venditti, Farida Latif, William S. Modi, Michael I. Lerman, Berton Zbar, David Robins, Peter K. Rogan, Roger L. Ladda	1993	37
19	Long range restriction map of the von Hippel-Lindau gene region on human chromosome 3p Human Genetics ·Rafael Luiz Martins, Holger Hummerich, Farida Latif, Ein Produkt Der Einbildungskraft, J. M. Janus, 村上佳津美	1993	3
20	Isolation and regional localization of a large collection (2,000) of single-copy DNA fragments on human chromosome 3 for mapping and cloning tumor suppressor genes Human Genetics ·Ein Produkt Der Einbildungskraft, Farida Latif, J. F. Siegfried, L.N. Daniel, Hiltrud Brauch, Shigeto Hosoe, И С Новоженова, Deo Vikas, Jieqing Zeng, O. Wesley McBride, Karl‐Heinz Grzeschik, Takashi Takahashi, J D Minna, Patrick Anglard, W. Marston Linehan, Berton Zbar	1991	38

About Farida Latif

Farida Latif is a scholar working on Cancer Research, Molecular Biology, Cell Biology, Oncology and Pulmonary and Respiratory Medicine, having authored 190 papers that have together received 14.2k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (73 papers), Cancer-related gene regulation (40 papers), Cancer, Hypoxia, and Metabolism (26 papers), RNA modifications and cancer (25 papers), Renal cell carcinoma treatment (20 papers), Cancer Genomics and Diagnostics (18 papers), Renal and related cancers (18 papers) and Hippo pathway signaling and YAP/TAZ (17 papers). The work is most often cited by research in Cancer Research (4.4k citations), Molecular Biology (10.6k citations), Cell Biology (1.7k citations), Pulmonary and Respiratory Medicine (2.6k citations) and Oncology (2.0k citations). Farida Latif has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Eamonn R. Maher, Michael I. Lerman, Ashraf Dallol, Luke B. Hesson, Berton Zbar, Wendy N. Cooper, Angelo Agathanggelou, Mark R. Morris, John D. Minna and Dewi Astuti. Their work appears in journals such as Nucleic Acids Research, Oncogene, Cancer Research, Epigenetics and Human Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact